Status:
COMPLETED
Retinal Imaging Using NOTAL-OCT
Lead Sponsor:
Notal Vision Ltd.
Conditions:
Age-Related Macular Degeneration
Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Brief Summary
Comparison between retinal measurements, done by the Notal-OCT imaging and a commercial OCT (Optical Coherence Tomography)
Eligibility Criteria
Inclusion
- Ability and agreement to give informed consent (IC)
- Diagnosis of AMD or DR in SE by OCT
- Ability to undergo OCT scans
- VA of 20/160 or better in SE
Exclusion
- AMD and DR in the same SE
- Evidence of macular disease other than AMD or DME in SE
Key Trial Info
Start Date :
January 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT03374020
Start Date
January 17 2017
End Date
December 1 2018
Last Update
November 13 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.